 Connection
Kathleen Adelgais to Midazolam
This is a "connection" page, showing publications Kathleen Adelgais has written about Midazolam.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.485 |
|
|
|
-
Shah MI, Adelgais KM, Chamberlain JM, Wang HE, Morgan LA, Riviello JJ, Said RR, Sullivan JE, Ghaffari KF, Kothari KM, Saidinejad M, Lowe RA, Fowler RL, Counts CR, Morris CR, Studnek JR, Glober NK, Ward CE, Clemency BM, Patrick N, Munn RD, Brant-Zawadzki GM, Martin-Gill C, Nishijima DK, Li K, Sepulveda N, VanBuren JM. Methodology for the Pediatric Dose Optimization for Seizures in Emergency Medical Services (PediDOSE) study. Trials. 2025 Dec 13; 27(1):53.
Score: 0.228
-
Mellion SA, Bourne D, Brou L, Brent A, Adelgais K, Galinkin J, Wathen J. Evaluating Clinical Effectiveness and Pharmacokinetic Profile of Atomized Intranasal Midazolam in Children Undergoing Laceration Repair. J Emerg Med. 2017 Sep; 53(3):397-404.
Score: 0.128
-
Holsti M, Dudley N, Schunk J, Adelgais K, Greenberg R, Olsen C, Healy A, Firth S, Filloux F. Intranasal midazolam vs rectal diazepam for the home treatment of acute seizures in pediatric patients with epilepsy. Arch Pediatr Adolesc Med. 2010 Aug; 164(8):747-53.
Score: 0.079
-
Ward CE, Adelgais KM, Holsti M, Jacobsen KK, Simon HK, Morris CR, Gonzalez VM, Lerner G, Ghaffari K, VanBuren JM, Lerner EB, Shah MI. Public support for and concerns regarding pediatric dose optimization for seizures in emergency medical services: An exception from informed consent (EFIC) trial. Acad Emerg Med. 2024 07; 31(7):656-666.
Score: 0.050
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|